Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · Real-Time Price · USD

7.06

+0.31 (4.59%)

At close: Aug 19, 2026, 4:00 PM EDT

7.18

+0.12 (1.70%)

After-hours: Aug 19, 2026, 6:54 PM EDT

Foghorn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	419	305	262	272	267	848
Market Cap Growth	48.93%	16.38%	-3.64%	2.10%	-68.56%	17.59%
Enterprise Value	295	148	34	59	-54	807
Last Close Price	7.06	5.40	4.72	6.45	6.38	22.87
PS Ratio	11.41	9.88	11.61	7.97	13.87	643.15
PB Ratio	-	-2.81	-5.76	-3.53	2381.22	8.76
P/TBV Ratio	-	-	-	-	2381.22	8.76
P/FCF Ratio	-	-	-	-	1.39	-
P/OCF Ratio	-	-	-	-	1.38	-
EV/Sales Ratio	8.02	4.78	1.51	1.74	-	612.13
Debt / Equity Ratio	-0.53	-0.38	-0.82	-0.58	459.88	0.60
Debt / FCF Ratio	-	-	-	-	0.27	-
Net Debt / Equity Ratio	1.54	1.08	4.54	2.45	-2627.60	-0.99
Net Debt / EBITDA Ratio	1.88	1.49	2.13	1.81	2.59	0.98
Net Debt / FCF Ratio	1.48	1.37	2.04	1.58	-1.53	1.79
Asset Turnover	0.17	0.13	0.08	0.10	0.04	0.00
Quick Ratio	3.31	2.66	3.64	4.01	6.26	9.33
Current Ratio	3.36	2.73	3.73	4.11	6.37	9.44
Return on Equity (ROE)	-	-	-	-	-224.54%	-83.37%
Return on Assets (ROA)	-19.92%	-21.29%	-22.00%	-19.53%	-15.83%	-16.24%
Return on Capital Employed (ROCE)	-44.80%	-59.30%	-46.20%	-47.40%	-33.50%	-21.40%
Earnings Yield	-15.40%	-24.32%	-33.01%	-36.15%	-40.83%	-11.94%
FCF Yield	-20.10%	-28.21%	-38.61%	-43.82%	72.14%	-6.31%
Buyback Yield / Dilution	-5.91%	-14.72%	-30.79%	-0.92%	-11.89%	-236.49%

SEC Filings: 10-K · 10-Q